Welcome to PRI
Founded in 2002, PRI at Albany College of Pharmacy and Health Sciences is a center for drug discovery and development
EXPERTISE Nanotechnology, Medicinal Chemistry, Molecular Biology, Cell Biology
FOCUS Hematology/Oncology, Cardiovascular (Dyslipidemia), Ophthalmology, Vascular diseases, Neurology, Inflammation
TEACHING and LEARNING Pharmacy students, graduate students, visiting scholars from around the world visit PRI to conduct research and learn the latest advances across a wide range of therapeutic areas
ALBANY, NY – The Albany College of Pharmacy and Health Sciences (ACPHS) is pleased to announce that Dr. Shaker Mousa was recently awarded the first Sheikh Zayed International Award in Traditional Complementary and Alternative Medicine (TCAM) for improved human health and quality of life.
“My goal inspired by this prestigious award is to utilize emerging nanotechnology and biotechnology, along with the latest emerging technologies, in advancing valuable natural treasures not only in disease prevention, but also in better disease management and therapeutics,” said Dr. Mousa.
In recent years, Dr. Mousa and the PRI team have been focusing on nanotechnology applications for health and medicine. Nanomedicine is an evolving field of biomedical research that has demonstrated great potential for improving drug and gene delivery. Kudos to Dr. Mousa!
17 Annual International Conference – The Road from Nanomedicine to Precision Medicine
1-Day event held on ACPHS Campus
October 21, 2019 – View the full brochure and schedule
Congratulations Dr Mousa !
Shaker A. Mousa elected Fellow of the National Academy of Inventors (NAI) – class of 2018! Election to NAI Fellow status is the highest professional distinction accorded to academic inventors who have demonstrated a prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development and the welfare of society. The 2018 NAI Fellows class was inducted at the Space Center Houston in April at the Eighth Annual Meeting of the NAI.
Dr. Paul Davis selected as Top Endocrine Pharmacologist for 2018 by the International Association of Top Professionals (IAOTP) for his outstanding leadership and commitment to the profession.
Dr. Davis is Adjunct Professor of Pharmacy at the Albany College of Pharmacy and Health Sciences and a Professor of Medicine at Albany Medical College.
CONGRATULATIONS Dr. Davis!
Dr. Mousa served as Co-chairman of the
Nanotechnology: Theory and Applications
Cairo, Egypt, December 10-13, 2018
PRI Executive Director Wins the Kuwait Prize
Congratulations Dr. Mousa !
Dr. Shaker Mousa has been named a 2017 recipient of the Kuwait Prize, one of the world’s most prestigious awards for achievements in science.
Sponsored by the Kuwait Foundation for the Advancement of Sciences (KFAS), this annual award recognizes lifetime contributions of Arab scientists across the globe. Dr. Mousa was honored in the category of Applied Sciences (Applied Medical & Applied Allied Health Sciences). The Kuwait Prize was first awarded in 1979. Award recipients are selected based on evaluations from local and international scientific institutions.
“It is my great honor to receive the Kuwait Prize for Applied Sciences, and I wish to thank the KFAS for using this awards program to stimulate interest in the scientific community and help inspire further advances,” said Dr. Mousa. “I truly believe that science knows no boundaries. The only chance we have to find better therapies for complex diseases is for the global scientific community to work together, and I value being part of that process.”
PRI Celebrates 15 Years !!
Left to Right: W. Li, K. Godugu, S.A. Mousa, P. Phillips. M. Jayaraman, D. Bharali, S. Thangirala,
M. Rajabi, B. Hay, K. Keating, O. Karakus
Antidiabetic effects of novel ellagic acid nanoformulation: Insulin-secreting and anti apoptosis effects
Steve Harakeh, Mohammed Almuhayawi, Soad Al Jaouni, Saad Almasaudi, Saber Hassan, Turki Al Amri, Najiah Azhar, Elham Abd-Allah, Soad Ali, Nagla El-Shitany, Shaker A. Mousa Abstract Antioxidants are one of the effective treatment lines in managing type 2 diabetes (typ2diab) and its complications. Nanoformulations could help in ameliorating the oral bioavailability and biocompatibility properties. Ellagic…Read more
Newly released article titled “Anti-integrins” by Shaker A. Mousa and Paul J. Davis with the Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences and Albany Medical College in Albany, New York. Please click below to read more. Anti-integrinsRead more